» Articles » PMID: 12659674

Hybrid Yeast-bacteria Cloning System Used to Capture and Modify Adenoviral and Nonviral Genomes

Overview
Journal Hum Gene Ther
Specialties Genetics
Pharmacology
Date 2003 Mar 28
PMID 12659674
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Adenoviral vectors are widely used to express transgenes in vitro and in vivo. A major obstacle to the generation of adenoviral vectors is the manipulation of the large (35 kb) adenoviral genome. We developed a hybrid yeast-bacteria cloning system for the creation of novel adenoviral vectors. The adenovirus 5 (Ad5) genome was cloned into a shuttle vector that contains both yeast and bacterial elements for replication and therefore functions as both a yeast artificial plasmid (YAP) and as a plasmid artificial chromosome (PAC). Any sequence can be introduced into any region of the adenoviral genome via the highly efficient homologous recombination in yeast and then these recombinants are rapidly amplified in bacteria. Adenoviral vectors are generated by introduction of the PAC into the appropriate complementing mammalian cell without the need for plaque purification. Vectors were constructed with deletions in the E1, E3, and/or E4 regions. We have generated more than 100 vectors with a number of different transgenes and regulatory elements. In addition, the YAP/PAC vector was used to capture a DNA fragment encompassing the human factor IX gene, demonstrating the utility of this system to clone and analyze genomic DNA. This novel cloning strategy allows the rapid and versatile construction of adenoviral vectors for gene expression and gene therapy applications.

Citing Articles

Adenoviral Gene Therapy Vectors in Clinical Use-Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety.

Leikas A, Yla-Herttuala S, Hartikainen J Int J Mol Sci. 2023; 24(22).

PMID: 38003709 PMC: 10671366. DOI: 10.3390/ijms242216519.


The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems.

Wang L, Chen Y, Liu X, Li Z, Dai X Front Oncol. 2022; 11:704999.

PMID: 35111663 PMC: 8801488. DOI: 10.3389/fonc.2021.704999.


Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Teng M, Yao Y, Nair V, Luo J Viruses. 2021; 13(5).

PMID: 33924851 PMC: 8146441. DOI: 10.3390/v13050779.


CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses.

Yuan M, Webb E, Lemoine N, Wang Y Viruses. 2016; 8(3):72.

PMID: 26959050 PMC: 4810262. DOI: 10.3390/v8030072.


An exogenous chloroplast genome for complex sequence manipulation in algae.

ONeill B, Mikkelson K, Gutierrez N, Cunningham J, Wolff K, Szyjka S Nucleic Acids Res. 2011; 40(6):2782-92.

PMID: 22116061 PMC: 3315318. DOI: 10.1093/nar/gkr1008.